Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KGM-CUR + PSM is a research-stage nutraceutical delivery system consisting of a **konjac glucomannan (KGM)** and **curcumin (CUR)** complex encapsulated within **porous starch microspheres (PSM)**. This formulation is designed to overcome the inherent limitations of curcumin, such as poor aqueous solubility, low chemical stability, and rapid metabolism. In this system, KGM acts as a stabilizer and film-forming agent that complexes with curcumin, while the porous starch microspheres serve as a high-surface-area carrier that protects the complex from degradation in the upper gastrointestinal tract. The combination allows for the sustained and controlled release of curcumin, primarily targeting the lower digestive system. This delivery platform is investigated for its potential in functional foods and therapeutic applications involving curcumin's antioxidant and anti-inflammatory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on konjac glucomannan-curcumin complex in porous starch microspheres.